Chronic sleep deprivation accelerates atherosclerosis by disrupting immune cell balance, according to a 2026 research study. The research shows that lack of sleep reduces a protective protein called NFIL3 in immune cells, allowing inflammatory Th17 cells to multiply excessively while protective Treg cells decrease. Gram Research analysis of this study found that blocking IL-17A, an inflammatory protein produced by these cells, significantly slowed disease progression in mice. This suggests that adequate sleep is crucial for maintaining immune balance and cardiovascular health.
Chronic sleep deprivation, the kind that happens when you regularly don’t get enough rest, appears to accelerate atherosclerosis, a condition where fatty deposits build up in your arteries. According to Gram Research analysis, a new study found that lack of sleep disrupts your immune system’s balance, specifically triggering more inflammatory cells called Th17 cells while reducing protective cells called Treg cells. Researchers discovered that blocking a specific inflammatory protein called IL-17A could slow down this process in mice. This research suggests that getting adequate sleep may be even more important for heart health than previously thought, and that targeting this immune pathway could offer a new way to treat heart disease in people who struggle with sleep problems.
Key Statistics
A 2026 research study found that mice experiencing chronic sleep deprivation developed significantly more atherosclerotic plaque and less stable plaques compared to mice that slept normally, demonstrating a direct link between sleep loss and accelerated heart disease.
According to the 2026 research, chronic sleep deprivation reduced NFIL3 protein levels in immune cells by allowing RORγt to become overactive, driving excessive production of inflammatory Th17 cells and reducing protective Treg cells.
The 2026 study demonstrated that blocking IL-17A, an inflammatory protein, substantially attenuated atherosclerosis progression in sleep-deprived mice and reduced endothelial inflammation, validating it as a potential therapeutic target.
Research showed that conditioned medium from Th17 cells derived from sleep-deprived mice markedly induced apoptosis and inflammatory activation in blood vessel cells, effects that were significantly reduced by IL-17A neutralization.
The Quick Take
- What they studied: Whether chronic sleep deprivation speeds up atherosclerosis (clogged arteries) and whether blocking a specific immune protein could slow this process down.
- Who participated: Laboratory mice that were genetically prone to developing clogged arteries. Some mice were kept awake chronically while others slept normally, and all were fed a high-fat diet similar to a Western diet.
- Key finding: Mice that didn’t sleep enough developed significantly more arterial plaque buildup and had more unstable plaques. When researchers blocked IL-17A, a protein that causes inflammation, the disease progression slowed considerably.
- What it means for you: This research suggests that chronic sleep deprivation may be a direct cause of heart disease risk, not just a side effect. If confirmed in humans, it could mean that improving sleep quality might help prevent heart disease, and that new treatments targeting IL-17A could help people at risk.
The Research Details
Researchers used mice that were genetically engineered to develop clogged arteries easily, similar to how some humans are predisposed to heart disease. They divided the mice into two groups: one group was kept awake chronically (not allowed to sleep normally) for 12 weeks, while the other group slept normally. Both groups ate a high-fat diet to mimic typical Western eating patterns. The researchers then examined the mice’s arteries to see how much plaque had built up and whether the plaques were stable or likely to rupture. They also analyzed the immune cells in the mice’s blood and tissues using advanced techniques to understand what was happening at the cellular level. Additionally, they studied immune cells in laboratory dishes to understand the exact mechanisms involved.
This research approach is important because it allows scientists to understand the step-by-step biological process linking sleep loss to heart disease. By studying mice, researchers can control variables precisely and examine tissues directly, which isn’t possible in humans. The combination of studying whole animals, individual cells, and molecular pathways provides a complete picture of how sleep deprivation damages the cardiovascular system.
This is a laboratory-based mechanistic study, which means it’s excellent for understanding how something works but doesn’t directly prove the same thing happens in humans. The study used multiple complementary techniques including genetic analysis, cell imaging, and protein measurement, which strengthens confidence in the findings. However, mice don’t always respond the same way humans do to biological processes, so results need confirmation in human studies before changing medical practice.
What the Results Show
Mice that experienced chronic sleep deprivation developed significantly more atherosclerotic plaque in their arteries compared to mice that slept normally. The plaques in sleep-deprived mice were also less stable, meaning they were more likely to rupture and cause a heart attack or stroke. When researchers examined the immune system, they found that sleep deprivation caused an imbalance: there were more inflammatory Th17 cells (which promote disease) and fewer protective Treg cells (which reduce inflammation). The mechanism behind this involved a circadian rhythm protein called NFIL3 that normally keeps Th17 cells in check. Sleep deprivation reduced NFIL3 levels, allowing another protein called RORγt to become overactive and drive excessive Th17 cell production. When researchers blocked IL-17A, the inflammatory protein produced by Th17 cells, the disease progression slowed significantly and the arteries remained healthier.
The study showed that the inflammatory medium produced by Th17 cells from sleep-deprived mice caused damage to the cells lining blood vessels when applied in laboratory conditions. This damage included increased cell death and inflammatory activation. When IL-17A was neutralized in these experiments, the damage was substantially reduced. The research also identified specific signaling pathways disrupted by sleep deprivation through genetic analysis, providing multiple potential targets for future treatments.
Previous research has shown that sleep deprivation increases heart disease risk, but the exact biological mechanisms were unclear. This study provides a detailed explanation of one major pathway: sleep loss disrupts circadian rhythm control of immune cells, leading to excessive inflammation. This adds to growing evidence that circadian rhythms (your body’s internal 24-hour clock) are crucial for maintaining immune balance and cardiovascular health. The finding that IL-17A is a key driver aligns with other research showing this protein’s role in various inflammatory diseases.
This research was conducted in mice, not humans, so the results may not translate directly to people. The study used genetically modified mice prone to heart disease, which may respond differently than humans with normal genetics. The research doesn’t show whether improving sleep in sleep-deprived mice would reverse the damage already done. Additionally, the study doesn’t examine whether other factors that disrupt sleep (like shift work or sleep apnea) cause the same immune imbalance through the same pathway.
The Bottom Line
Based on this research, prioritizing consistent, adequate sleep appears important for heart health, particularly for people with risk factors for atherosclerosis. The evidence suggests that 7 to 9 hours of quality sleep nightly may help maintain immune balance and reduce cardiovascular inflammation. While these findings are promising, they’re based on animal research, so people shouldn’t rely solely on sleep improvement without following other established heart disease prevention strategies like exercise, healthy diet, and medical treatment if needed. The IL-17A blocking approach shows promise but requires human testing before it becomes a standard treatment.
Anyone concerned about heart disease risk should pay attention to these findings, especially people with family histories of heart disease, high cholesterol, or other cardiovascular risk factors. People who work irregular hours or have chronic sleep problems should discuss sleep improvement strategies with their doctors. People already diagnosed with atherosclerosis or heart disease may benefit from discussing whether sleep optimization could be part of their treatment plan. However, these findings don’t yet apply to people without cardiovascular risk factors, though good sleep is beneficial for overall health regardless.
If sleep improvement is the intervention, benefits to immune balance might begin within days to weeks, but measurable improvements in arterial health would likely take months to years. If IL-17A blocking therapy becomes available for humans, the timeline for cardiovascular benefits would depend on the specific treatment and individual factors. It’s important to have realistic expectations: improving sleep won’t instantly reverse existing arterial damage, but it may slow progression and reduce future risk.
Frequently Asked Questions
Does not sleeping enough really cause heart disease?
Research shows chronic sleep deprivation accelerates atherosclerosis through immune system disruption. A 2026 study found sleep loss reduces protective proteins and increases inflammatory cells that damage arteries. While this research is in mice, it provides a biological mechanism explaining why sleep-deprived people have higher heart disease risk.
How much sleep do I need to protect my heart?
Most health experts recommend 7 to 9 hours of consistent sleep nightly for cardiovascular health. This study suggests that maintaining regular sleep patterns helps keep immune cells balanced and reduces arterial inflammation. Consistency matters as much as duration.
What is IL-17A and why does blocking it help?
IL-17A is a protein that causes inflammation. Sleep deprivation triggers immune cells to produce excess IL-17A, which damages blood vessel cells and promotes plaque buildup. The 2026 research found that blocking IL-17A slowed atherosclerosis progression, suggesting it could become a future treatment.
Can improving my sleep reverse existing heart disease?
This study doesn’t show whether improving sleep reverses existing damage. However, better sleep may slow disease progression and reduce future risk by maintaining immune balance. Anyone with existing heart disease should discuss sleep optimization with their doctor as part of comprehensive treatment.
When will this IL-17A treatment be available for people?
The IL-17A blocking approach is currently in early research stages using mice. Human clinical trials would need to occur before any new treatment becomes available, which typically takes several years. Existing heart disease treatments remain the standard of care.
Want to Apply This Research?
- Track nightly sleep duration and quality using the app’s sleep logging feature, aiming for 7 to 9 hours consistently. Record any factors that disrupt sleep (stress, caffeine, screen time) to identify patterns and opportunities for improvement.
- Set a consistent bedtime and wake time seven days a week, even on weekends. Use the app to set reminders to avoid screens one hour before bed and to avoid caffeine after 2 PM. Track how these changes affect your sleep quality over two to four weeks.
- Monitor sleep metrics weekly and correlate them with other health markers tracked in the app, such as stress levels, exercise, and diet quality. Over months, look for trends in how consistent sleep relates to your overall cardiovascular health markers and energy levels.
This article summarizes laboratory research in mice and does not constitute medical advice. The findings have not been confirmed in humans. Anyone with sleep problems, cardiovascular risk factors, or existing heart disease should consult their healthcare provider before making changes to their treatment plan or sleep habits. Do not stop taking prescribed medications or change your medical care based on this research. This study provides potential future directions for treatment but does not change current medical recommendations.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.